iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
₹2,368.5
(-0.48%)
Oct 9, 2026|03:31:43 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
00%₹654.7 0%2,000₹2.15 -29.5%18,500-2.63%
00%₹617.65 0%2,040₹9.1 0%00%
00%₹581.15 0%2,080₹12 0%00%
--2,100₹4.3 -46.25%13,750-39.56%
00%₹545.35 0%2,120₹6 -61.66%3,0000%
00%₹282.65 0%2,140₹5.9 -45.87%4,750-9.52%
00%₹510.35 0%2,160₹7 -46.96%10,00029.03%
00%₹252.95 0%2,180₹8.95 -44.23%4,75011.76%
2500%₹108 0%2,200₹10.5 -43.54%34,0000.74%
00%₹224.85 0%2,220₹12.25 -47.53%4,2500%
00%₹443.15 0%2,240₹17.15 -38.85%7,5003.44%
00%₹198.75 0%2,260₹20.25 -39.46%16,7504.68%
7500%₹106.75 0%2,280₹24.7 -37.7%20,7502.46%
10,7500%₹107 19.35%2,300₹30.6 -35.03%61,750-5.72%
2,25012.5%₹90.85 14.56%2,320₹37.05 -34.59%18,75036.36%
9,50022.58%₹81.6 19.73%2,340₹44.8 -31.7%14,75043.90%
19,750558.33%₹68.75 16.62%2,360₹53.55 -29.11%24,50027.27%
21,7502075%₹57.05 12.3%2,380₹63.65 -29.39%18,75087.5%
73,250-19.06%₹49.9 13.4%2,400₹73.1 -26.04%48,750-7.14%
19,00043.39%₹42 12%2,420₹118.6 0%31,0000%
12,00026.31%₹34.65 8.62%2,440₹130.1 0.57%17,5000%
36,7505.75%₹29.5 10.48%2,460₹113.15 -19.89%45,000-3.22%
42,25023.35%₹24.15 6.38%2,480₹128.45 -20.34%38,750-1.27%
1,94,5000.25%₹19.8 3.39%2,500₹132 -25.98%80,750-4.15%
50,750-0.49%₹17.15 4.57%2,520₹157.75 -11.67%44,750-1.10%
72,0008.27%₹14.65 4.27%2,540₹180.6 0%7500%
24,75045.58%₹11.5 0.43%2,560₹126.45 0%00%
34,0003.81%₹10.05 -2.42%2,580₹199.5 0%7500%
1,46,2500.86%₹8.15 -5.78%2,600₹270 1.61%5,7500%
7,75010.71%₹7 -2.09%2,620₹277.3 0%00%
8,500-12.82%₹6.35 1.59%2,640₹250 0%2500%
9,250-2.63%₹4.8 -6.79%2,660₹308.45 0%00%
18,5000%₹5.2 13.04%2,680₹185.4 0%00%
89,00015.58%₹3.7 -8.64%2,700₹200 0%2500%
2,500-33.33%₹3.4 -10.52%2,720₹337.05 0%2500%
3,500-36.36%₹2.75 -16.66%2,740--
3,7500%₹5.95 0%2,760₹231.7 0%00%
7500%₹5 0%2,780--
36,500-11.51%₹1.9 -11.62%2,800--
13,5001.88%₹1.55 -50.79%2,840₹355 0%2500%
500-60%₹1.65 -64.89%2,860--
10,5000%₹1.5 0%2,880--
49,5000%₹1.1 0%2,920--

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.